Skin glow test may spot hidden sexual health issues in diabetics

NCT ID NCT02770235

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at 97 men with type 2 diabetes to see if a non-invasive skin test for advanced glycation end-products (AGEs) could be linked to erectile dysfunction. AGEs build up due to high blood sugar and may damage blood vessels. Researchers used a device called AGE-ReaderTM to measure skin auto-fluorescence, aiming to find a simple way to screen for erectile dysfunction and improve overall diabetes care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive screening tool to detect erectile dysfunction and cardiovascular risk in diabetic patients.
What could go wrong: This is an observational study, not a treatment trial. The link between AGEs and erectile dysfunction is still unproven, and the small size (97 participants) limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, NON-INSULIN-DEPENDENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, NON-INSULIN-DEPENDENT ERECTILE DYSFUNCTION

Contacts and locations

Locations

CHU Amiens

Amiens, 80000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.